Navigation Links
Silence Therapeutics Announces Board Changes
Date:7/1/2008

Appoints Annette Clancy and Jerry Randall as non-executive directors

LONDON, July 1 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN) ('the Company') today announced changes to its Board of Directors as part of the company's plan for growth.

Effective today, Silence has appointed Annette Clancy and Jerry Randall as non-executive directors and Iain Rugheimer has resigned as a director of the Company.

Annette Clancy is joining the Board in her first non-executive director role. Ms. Clancy (53) is currently with GlaxoSmithKline (GSK), where she has had a distinguished career spanning 30 years, and will be leaving GSK at the end of the year. She has 15 years experience in Business Development, leading GSK's global Transactions and Alliance Management teams for the past 3 years, and during her tenure she and her team have been responsible for concluding a large number of research, development and commercial business collaborations on behalf of GSK. Prior to her role in Business Development, Ms. Clancy held a number of positions in Clinical Research, R&D project management and Commercialization. Ms. Clancy has a BSc (Hons) Pharmacology from Bath University.

Jerry Randall has been Chief Financial Officer of Sinclair Pharmaceuticals plc since 2000 when he joined as part of a management buy-in team. Prior to this, Mr. Randall worked in corporate finance with Gambit Corporate Finance. Previously, Mr. Randall had been involved in two other buy-ins and acted as adviser to both private and quoted companies between 1993 and 2000, in both the capacity as nominated adviser and in practice with KPMG. During this period, Mr. Randall (43) was involved in a number of flotations and transactions on the Official List, Unlisted Securities Market and the Alternative Investment Market, as well as raising private equity. Mr. Randall qualified as a chartered accountant with KPMG in 1990. Mr. Randall has a beneficial interest in 10,000 ordinary share
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasda...productsforminimallydisruptivesurgicaltreatmentsfo...allonMonday,November30,2009,at5:30p.m.ET/2:30p.m.P...etoreimbursementfortheCompany,sproductsandwillincl...ndanswersession.Thedial-innumbersare1-877-407-4018...
(Date:11/25/2009)...Nov.25/PRNewswire/--Reportlinker.comannouncesthata...,, PainManagement-GlobalTrends ,, http:...Global-Trends.html ,, Widespreadavailabilityof...headventofnewdrugshaveacceleratedthepaceofgrowthin...rsementstructurecontinuetoshapedemandforservices,d...
(Date:11/25/2009)...eNetherlandsandJOHANNESBURG,November25/PRNewswire/...iscoveryannouncedtoday,thattheyhavesignedacollabor...es. , Pyxis,sworldclasscomputationalchemistry...,sservicedivisiontoprovidemedicinaland,syntheticch...ternationalclientnetwork.iThembaPharmaceuticalsand...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Social class gender and ethnic group determine adolescents sexual affective education 49932 1Social class gender and ethnic group determine adolescents sexual affective education 49932 2Canadian excellence strengthened by extensive adoption of open access 8983 1Canadian excellence strengthened by extensive adoption of open access 8983 2PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2
...cals (Nasdaq: BCRX ) today announced that the fu...eramivir in patients hospitalized for influenza wa... Dr. Michael G. Ison, Assistant Professor, Divisio...n at Northwestern University Feinberg School of ... Respiratory Viral Infections taking place in Bang...
...national team of,researchers has evaluated the eff... of the knee, and the results have been published ..."Osteoarthritis and Cartilage".,The researchers fo... of,various osteoarthritis treatments. After six m...eived Orthokine therapy experienced significantly ...
Other Medicine Technology:Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 2Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 4Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 5New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years 2
(Date:11/26/2009)...Withcoldandfluseasonuponus,it,smoreimportantthanev...onsandavoidillness. ,, "Weneedtobeproactivenoto...lnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(cert...ioncontrolandoccupationalhealthatHospitalforSpecia...Surgeryhasoneofthelowestinfectionratesofanyhospita...
(Date:11/26/2009)...emotional rollercoaster, study finds , ,... fear factor meets the jubilant sports fan. , A...those who root for the winning team -- enjoy the g...atch and victory was in doubt, producing feelings ...Thanksgiving weekend as you,re glued to the TV set...
(Date:11/26/2009)...; Ennis, P.A. is offering free nationwide confiden...th control pills who have suffered a Deep Vein Thr...ttack or other related cardiac issues or had their...1-800-856-6405 or go to the firm’s website a... case evaluation form. , ...
(Date:11/25/2009)...entinelleMedicalInc.,aleadingmanufacturerofbreastM...iteofnewleadingedgeclinicalapplicationsonitsAegis(...logicalSocietyofNorthAmerica(RSNA)annualmeetinginC...cationsleveragetheuniquehighqualityimagesgenerated...multipleimagingmodalitiesformulti-parametricassess...
(Date:11/25/2009)...Business,andPressJoinEfforttoEducate ,, MEMPHI...heNationalBipolarFoundationandtheMedicAlertFoundat...le"program,whichisnowbeingwidelyacceptedasaprevent...tionalBipolarFoundationreceivedaproclamationofendo...rnorofLouisianaMitchLandrieu.TheNationalBipolarFou...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
...a surrounding,published research citing the patien...est medical experts have stumbled onto a startling... research from the World Health,Organization publi...ow doctors using a simple checklist before surgery...
...al Lung Cancer Partnership is pleased to announce ...ital Medical Center the recipient of the 2009 Car...es two years of protected time for new investigato...s of DNA and plays a role in supporting aggressive...
...ring a teleconference on Monday, three experts wil... action iron supplement pill with virtually no gas... energy and nutritional benefits from iron to be a...w.p2binc.com ), a retail sales and marketing compa...
...ovations, a pioneer in,assisting clients to achiev...ce improvement through a device-free remote monito...engthening its management team with the,addition o...GO ) , Christopher Raphaelian, MPH, will lead ...
...oldings,Inc.,s, (NYSE: HRC ) fiscal 2009 first q...February 4, 2009. You are invited to participate ...2009 at 8 a.m. EST. , Earnings Release: Hill-...Wednesday, February 4, 2009. The release will als...
...cedure milestone as the system becomes available i...s the country , , ST. LOUIS, Jan. 16 To date, mo...cer treatment procedures have been conducted using... The TargetScan technology has been shown to accur...
Other Medicine News:Health News:America's Best Hospitals Way Ahead of World Health Organization on Surgical Checklist Use 2Health News:Teleconference on Monday, January 19, Announcing New, Innovative Dual Iron Supplement Now Available Over the Counter 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 3Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast 2Health News:Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists 2
RT-600
...ractor. The RT-300's accessory knob is positioned ...ols are within a hand's breadth of each other. Cyl...5 to -19.00D. "Sure-grip" knurls on the control kn...venient placement of the controls themselves, this...
Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder Black
Double Maddox
Medicine Products: